Related Experiment Video

Updated: Feb 12, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.8K

Polyhexanide 0.2% in treatment of trophic foot ulcers in leprosy - preliminary study

Túlio Neutzling Zanchin1, Cássio Battisti Serafini2, Francine Silva Brandão3

  • 1Department of Dermatology, Instituto de Dermatologia Prof. Rubem David Azulay - Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA-SCMRJ) - Rio de Janeiro (RJ), Brazil.

Anais Brasileiros De Dermatologia
|April 12, 2018
PubMed

Insights

This study explores polyhexanide 0.2% for treating chronic trophic leprosy ulcers, aiming to improve patient outcomes and prevent further nerve and skin damage from Mycobacterium leprae infection.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Neurology

Background:

  • Leprosy, caused by Mycobacterium leprae, is a chronic infectious disease impacting peripheral nerves, skin, and mucous membranes.
  • Neural impairment and sensorimotor disabilities are significant challenges in leprosy management, necessitating strategies to prevent sequelae.
  • Chronic trophic ulcers are a common complication of leprosy, often exhibiting resistance to various therapeutic interventions.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of polyhexanide 0.2% in managing trophic ulcers associated with leprosy.
  • To assess the impact of polyhexanide 0.2% on the healing process and chronicity of leprosy-related ulcers.

Main Methods:

  • A clinical study involving eight patients with thirteen trophic leprosy ulcers.
  • Application of polyhexanide 0.2% products for therapeutic management of the ulcers.

Main Results:

  • The study details the therapeutic management of thirteen trophic leprosy ulcers in eight patients.
  • The use of polyhexanide 0.2% products was investigated for its effectiveness in treating these chronic ulcers.

Conclusions:

  • Polyhexanide 0.2% shows potential as a treatment for chronic trophic leprosy ulcers.
  • Further research is warranted to confirm the efficacy and optimal use of polyhexanide in leprosy ulcer management.

More Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.6K
Evaluating the Function of the Foot Core System in the Elderly08:25

Evaluating the Function of the Foot Core System in the Elderly

Published on: March 11, 2022

3.3K

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
535
Trophic Levels01:35

Trophic Levels

All organisms in an ecosystem occupy a trophic level in the food chain. The lowest level consists of primary producers, which synthesize their food from either solar or chemical energy. Each subsequent level obtains energy from the levels below. Detritivores can occupy any of the levels above primary producers.
37.8K
Trophic Efficiency00:46

Trophic Efficiency

Trophic level transfer efficiency (TLTE) is a measure of the total energy transfer from one trophic level to the next. Due to extensive energy loss as metabolic heat, an average of only 10% of the original energy obtained is passed on to the next level. This pattern of energy loss severely limits the possible number of trophic levels in a food chain.
25.3K
Muscles of the Leg that Move the Foot and Toes01:28

Muscles of the Leg that Move the Foot and Toes

The human leg comprises an intricate system of muscles that facilitate the movement of feet and toes. Within this system, the muscles are categorized into the anterior, lateral, and posterior compartments, each with a unique set of muscles carrying out specific functions.
Anterior Compartment
The anterior compartment includes muscles that contribute to the dorsiflexion of the foot. This compartment houses the tibialis anterior, extensor hallucis longus, and extensor digitorum longus muscles....
4.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
643
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K